Gainers

  • InflaRx N.V. (NASDAQ: IFRX) rose 47.9% to $4.23 in pre-market trading. Raymond James upgraded InflaRx from Outperform to Strong Buy and announced a $14 price target.

read more

Anheuser Busch Inbev SA NV (NYSE:BUD)
Historical Stock Chart
Von Mai 2022 bis Jun 2022 Click Here for more Anheuser Busch Inbev SA NV Charts.
Anheuser Busch Inbev SA NV (NYSE:BUD)
Historical Stock Chart
Von Jun 2021 bis Jun 2022 Click Here for more Anheuser Busch Inbev SA NV Charts.